Skip to main content

Table 4 Association between ESR SNPs and obesity in samples 1 and 2a

From: Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis – a cohort study

Gene

SNP

Controls (n)

Cases (n)

Allele Frequency

Heterozygous

Homozygous

Recessive model

Armitage's trend test

  

22b

21

11

22

21

11

[2]<-> [1]c

P value

[22]<-> [12]

P value

[22]<-> [11]

P value

[11+12]<-> [22]

P value

OR

P value

Sample 1

                 

ESR1

rs2813544

10

134

255

33

242

408

0.82 [0.66–1.02]

0,08

0.55 [0.26–1.14]

0,11

0.48 [0.24–1.00]

0,05

0.51 [0.25–1.04]

0,06

0,79

0,07

 

Women

8

114

213

29

194

339

0.83 [0.66–1.06]

0,13

0.47 [0.21–1.06]

0,06

0.44 [0.20–0.98]

0,04

0.45 [0.20–1.00]

0,04

0,79

0,13

 

Men

2

20

42

4

48

69

0.77 [0.45–1.31]

0,33

1.20 [0.20–7.08]

0,84

0.82 [0.14–4.68]

0,82

0.94 [0.17–5.30]

0,95

0,78

0,31

ESR2

rs7154455

107

167

47

273

260

62

0.70 [0.57–0.85]

0,0003

0.61 [0.45–0.82]

0,001

0.52 [0.33–0.80]

0,003

0.59 [0.44–0.78]

0,0002

0,7

0,0003

 

Women

84

144

43

223

219

45

0.63 [0.51–0.78]

0,00003

0.57 [0.41–0.80]

0,0008

0.39 [0.24–0.64]

0,0001

0.53 [0.39–0.73]

0,00007

0,62

0,00002

 

Men

23

23

4

50

41

17

1.18 [0.71–1.97]

0,51

0.82 [0.40–1.67]

0,58

2.0 [0.59–6.46]

0,27

0.99 [0.50–1.94]

0,97

1,26

0,53

 

rs3020450

177

163

44

353

237

59

0.78 [0.64–0.94]

0,01

0.73 [0.56–0.95]

0,02

0.67 [0.44–1.03]

0,07

0.72 [0.56–0.92]

0,01

0,8

0,01

 

Women

147

139

41

288

202

42

0.72 [0.58–0.89]

0,002

0.74 [0.55–1.00]

0,05

0.52 [0.33–0.84]

0,007

0.69 [0.52–0.91]

0,009

0,73

0,003

 

Men

30

24

3

65

35

17

1.17 [0.71–1.94]

0,54

0.67 [0.34–1.32]

0,25

2.61 [0.71–9.61]

0,14

0.89 [0.47–1.68]

0,72

1,32

0,57

ESR2

Women

                
 

rs1152582

54

171

110

127

274

161

0.80 [0.66–0.98]

0,03

0.68 [0.47–1.00]

0,04

0.62 [0.42–0.93]

0,01

0.66 [0.46–0.94]

0,02

0,8

0,03

 

rs1271572

59

172

104

130

281

151

0.82 [0.68–1.00]

0,05

0.74 [0.52–1.06]

0,1

0.66 [0.44–1.00]

0,04

0.71 [0.50–1.00]

0,05

0,82

0,04

 

rs1269056

53

175

107

127

275

158

0.81 [0.66–0.98]

0,03

0.66 [0.45–0.95]

0,03

0.62 [0.41–0.92]

0,02

0.64 [0.45–0.91]

0,01

0,8

0,03

ESR2

Men

                
 

rs4986938

4

30

30

20

59

45

0.64 [0.40–1.00]

0,05

0.39 [0.12–1.26]

0,11

0.30 [0.09–0.96]

0,04

0.35 [0.11–1.06]

0,05

0,6

0,05

Sample 2

                 

ESR2

rs3020450

326

245

41

410

332

60

1.08 [0.91–1.27]

0,39

1.08 [0.86–1.34]

0,51

1.16 [0.76–1.78]

0,48

1.09 [0.88–1.34]

0,42

1.08

0,38

 

Women

273

216

35

346

282

53

1.06 [0.89–1.27]

0,42

1.03 [0.81–1.31]

0,81

1.20 [0.76–1.88]

0,44

1.05 [0.84–1.32]

0,65

1.07

0,51

 

Men

53

29

6

64

50

7

1.18 [0.75–1.86]

0,46

1.42 [0.80–2.56]

0,23

0.97 [0.31–3.05]

0,95

1.35 [0.77–2.35]

0,29

1.11

0,46

 

rs7154455

318

248

46

399

341

63

1.06 [0.90–1.26]

0,45

1.10 [0.88–1.37]

0,42

1.09 [0.73–1.64]

0,67

1.09 [0.89–1.35]

0,40

1.06

0,44

 

Women

268

216

40

337

287

57

1.06 [0.89–1.27]

0,52

1.06 [0.83–1.34]

0,65

1.13 [0.73–1.75]

0,57

1.07 [0.85–1.34]

0,57

1.06

0,52

 

Men

50

32

6

62

54

6

1.11 [0.71–1.73]

0,64

1.36 [0.77–2.42]

0,29

0.81 [0.24–2.65]

0,72

1.27 [0.73–2.21]

0,74

1.05

0,63

  1. a) Shown are SNPs with P value < 0.05 in at least one analysis.
  2. b) 1 and 2 represent the two alleles of each SNP.
  3. c) OR (95% confidence interval)